GA28949: Phase III Randomized Double-Blind Double-Dummy Placebo-Controlled Multicenter Study to Evaluate the Efficacy (Induction of Remission) and Safety of Etrolizumab Compared with Adalimumab and Placebo in Patients with Moderate to Severe Ulcera
If you are registered as a volunteer, please log in to contact the study team/express interest in this study.
